Update:
✅ 5 of the highly awaited BC trials with positive results
❌ one negative trial (but with positive OS)
Results from the remaining trials expected in 2025.
Breast oncology keeps moving extremely fast.
Interesting validation analysis of TNBC-DX in over 500 patients with TNBC treated with neoadjuvant chemo+/-pembro. The multigene assay significantly predicted pCR, DDFS/EFS and OS.
We desperately need a biomarker to refine treatment for early-stage TNBC.
https://t.co/5bwf83nZ1K
Dr. Sara Tolaney (@stolaney1) discusses 3 studies presented at #ESMO24 which will impact clinical practice:
📎 Preoperative pembrolizumab in #TNBC
📎 Destiny Breast 12 Trial: #TDXd in metastatic HER2+ #BreastCancer +/- #BrianMetastases
📎 #NATALEE Trial: adj ribociclib for HR+ breast cancer
Watch here ⬇️
https://t.co/fM63NwZBan
#SuicidePrevention: Everyone copes and reacts differently, but there are some ‘warning’ signs you can look out for.
If you’re worried about someone, talk to them about how they are feeling, and encourage them to seek help https://t.co/Z7pUuqpO9g
#WorldSuicidePreventionDay